Gujarat Themis Biosyn Ltd.
GUJTHEM
Rank in Stocks
#11827
Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the... Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the creation of pharmaceuticals and medicinal chemicals. The firm also supplies bulk drugs via a job work model within India. Its product offerings include important compounds such as Rifamycin-S, an intermediate used in treatments for tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease. Another key product, Rifamycin-O, addresses ailments like traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Furthermore, they produce Lovastatin. Established in 1981, the company's operations are based out of Mumbai, India.
Share Price
$4.04
Last synced: 2026-11-09
Market Cap
$525.96M
Change (1 day)
0.40%
Change (1 year)
-20.52%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Gujarat Themis Biosyn Ltd. (GUJTHEM)
Category
Healthcare
Operating Margin for Gujarat Themis Biosyn Ltd. (GUJTHEM)
Operating Margin as of November 2026 TTM: 38.88%
According to Gujarat Themis Biosyn Ltd.'s latest financial reports, its current operating margin (TTM) is 38.88%. At the end of 2025 the company had an operating margin of 42.61%.
Operating Margin history for Gujarat Themis Biosyn Ltd. from 2022 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 38.88% | -8.75% |
| 2025 | 42.61% | -4.23% |
| 2024 | 44.49% | -9.11% |
| 2023 | 48.95% | -1.19% |
| 2022 | 49.54% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -99.50% |
DE
|
|
| 19.68% | -99.49% |
DE
|
|
| 13.26% | -99.66% |
JP
|
|
| 17.08% | -99.56% |
CH
|
|
| 14.92% | -99.62% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Gujarat Themis Biosyn Ltd.'s operating margin
What is Gujarat Themis Biosyn Ltd.'s operating margin?
Gujarat Themis Biosyn Ltd.'s operating margin is 38.88%, as of Nov 2026.
What was Gujarat Themis Biosyn Ltd.'s operating margin in 2025?
In 2025, Gujarat Themis Biosyn Ltd.'s operating margin was 42.61%, compared with 44.49% in 2024.
How has Gujarat Themis Biosyn Ltd.'s operating margin changed since 2022?
From 2022 to 2025, Gujarat Themis Biosyn Ltd.'s operating margin was highest in 2022 (49.54%) and lowest in 2025 (42.61%).
How does Gujarat Themis Biosyn Ltd.'s operating margin compare with similar companies?
Gujarat Themis Biosyn Ltd.'s operating margin (38.88%) is higher than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.